Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000
In a study by Lloyd-Jones et al,1 the impact of the recently published Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) on the number of subjects with hypertension who are eligible for treatment was estimated. Using data from the Framingham Heart Study, Lloyd-Jones et al estimated that according to the JNC-VI guidelines, 60.6% of the subjects in the high-normal or hypertensive group were eligible for initial drug therapy or were already receiving drug therapy. From the data that were presented in this study, it can be derived that 13.5% of the subjects in the high-normal or hypertensive group were eligible for initial pharmacological treatment.
Klungel OH, de Boer A, Seidell JC. Overestimation of the Number of Individuals With Hypertension Who Are Eligible for Treatment According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 2000;160(10):1537-1538. doi: